Additionally, AAV9-shMETTL3 or AAV9-FTO-overexpression via intravenous injection reportedly inhibits cardiac dysfunction and remodeling in mouse models of myocardial hypertrophy.329,362. This evidence concerns the gene FTO and cardiac hypertrophy.